Corbus director granted RSUs and stock options
Corbus Pharmaceuticals director Ben Yong received new equity awards as part of his compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Corbus Pharmaceuticals director Ben Yong received new equity awards as part of his compensation. On May 19, he was granted 3,800 restricted stock units that will convert into common shares after they vest in full one year from the grant date.
He also received stock options for 12,300 shares of common stock at an exercise price of $9.15 per share, which will also vest 100% after one year under the company’s 2024 Equity Compensation Plan. Following these awards, he directly holds 11,383 shares of common stock, including previously reported unvested RSUs.
Insider Trade Summary
Grant/Award: 16,100 shares
Grant/Award
2 txns
Insider
Ben Yong
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock options (right to buy) | 12,300 | $0.00 | $0.00 |
| Grant/Award | Common Stock, par value $0.0001 per share | 3,800 | $0.00 | $0.00 |
Holdings After Transaction:
Stock options (right to buy) — 12,300 contracts (Direct);
Common Stock, par value $0.0001 per share — 11,383 shares (Direct)
Footnotes (3)
- F1. On May 19, 2026, 3,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant.
- F2. This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported.
- F3. The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.
Key Figures
RSUs granted: 3,800 units
RSU vesting: 100% after 1 year
Options granted: 12,300 options
+3 more
6 metrics
RSUs granted
3,800 units
Restricted stock units granted on May 19, 2026
RSU vesting
100% after 1 year
Vests on one-year anniversary of grant date
Options granted
12,300 options
Stock options awarded on May 19, 2026
Option exercise price
$9.15 per share
Exercise price for 12,300 stock options
Shares held after transaction
11,383 shares
Direct common stock holdings after awards
Previously unvested RSUs
8,600 units
Unvested RSUs from prior grants included in total
Key Terms
restricted stock units ("RSUs"), vesting schedule, Equity Compensation Plan, stock options (right to buy)
4 terms
restricted stock units ("RSUs") financial
"On May 19, 2026, 3,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
vesting schedule financial
"This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
Equity Compensation Plan financial
"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan"
A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.
stock options (right to buy) financial
"Stock options (right to buy)"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Corbus (CRBP) director Ben Yong report?
Ben Yong reported receiving equity awards, not open-market trades. He was granted 3,800 restricted stock units and stock options for 12,300 shares, both vesting in one year, increasing his direct equity-based exposure to Corbus Pharmaceuticals.
How many Corbus (CRBP) restricted stock units did Ben Yong receive?
Ben Yong received 3,800 restricted stock units from Corbus Pharmaceuticals. These RSUs will settle in common stock and vest 100% on the one-year anniversary of the May 19, 2026 grant date, aligning his compensation with future company performance.
What stock options were granted to Corbus (CRBP) director Ben Yong?
Ben Yong was granted options covering 12,300 shares of Corbus common stock. The options have a $9.15 exercise price and were issued under the 2024 Equity Compensation Plan, vesting in full one year after the grant date, subject to plan terms.
Are Ben Yong’s Corbus (CRBP) equity awards immediately vested or deferred?
Both new awards are deferred through time-based vesting. The 3,800 RSUs and 12,300 stock options will each vest 100% on the one-year anniversary of the May 19, 2026 grant date, assuming continued service and satisfaction of plan conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
